Parallax Volatility Advisers’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,967
| Closed | -$10.7K | – | 792 |
|
|
2023
Q3 | $10.7K | Sell |
10,967
-5,727
| -34% | -$5.61K | ﹤0.01% | 598 |
|
|
2023
Q2 | $23.2K | Buy |
+16,694
| New | +$23.2K | ﹤0.01% | 584 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1187 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1181 |
|
|
2022
Q1 | – | Sell |
-28,178
| Closed | -$141K | – | 1093 |
|
|
2021
Q4 | $141K | Buy |
+28,178
| New | +$141K | ﹤0.01% | 524 |
|
|
2020
Q3 | – | Sell |
-17,800
| Closed | -$913K | – | 1216 |
|
|
2020
Q2 | $913K | Buy |
+17,800
| New | +$913K | ﹤0.01% | 525 |
|
|
2019
Q3 | – | Sell |
-21,763
| Closed | -$1.01M | – | 1169 |
|
|
2019
Q2 | $1.01M | Buy |
+21,763
| New | +$1.01M | ﹤0.01% | 332 |
|
|
2019
Q1 | – | Sell |
-27,653
| Closed | -$1.27M | – | 1574 |
|
|
2018
Q4 | $1.27M | Buy |
+27,653
| New | +$1.27M | ﹤0.01% | 336 |
|
|
2018
Q3 | – | Sell |
-10,655
| Closed | -$418K | – | 1561 |
|
|
2018
Q2 | $418K | Buy |
+10,655
| New | +$418K | ﹤0.01% | 355 |
|
|
2018
Q1 | – | Sell |
-2,562
| Closed | -$169K | – | 1733 |
|
|
2017
Q4 | $169K | Sell |
2,562
-7,907
| -76% | -$522K | ﹤0.01% | 1341 |
|
|
2017
Q3 | $525K | Buy |
10,469
+9,831
| +1,541% | +$493K | ﹤0.01% | 282 |
|
|
2017
Q2 | $30K | Sell |
638
-3,738
| -85% | -$176K | ﹤0.01% | 541 |
|
|
2017
Q1 | $155K | Buy |
+4,376
| New | +$155K | ﹤0.01% | 444 |
|